Solanum incanum  extract (SR-T100) induces melanoma cell apoptosis and inhibits established lung metastasis

Sebastian Yu; Hamm-Ming Sheu; Chih-Hung Lee

doi:10.18632/oncotarget.21508

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Solanum incanum extract (SR-T100) induces melanoma cell apoptosis and inhibits established lung metastasis

Sebastian Yu, Hamm-Ming Sheu and Chih-Hung Lee _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:103509-103517. https://doi.org/10.18632/oncotarget.21508

Metrics: PDF 1590 views | HTML 2583 views | ?

Abstract

Sebastian Yu1,2, Hamm-Ming Sheu3 and Chih-Hung Lee4

1Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

2Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

3Department of Dermatology, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan

4Department of Dermatology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan

Correspondence to:

Chih-Hung Lee, email: [email protected]

Keywords: melanoma, SR-T100, solamargine, Solanum incanum, immunotherapy

Received: March 06, 2017 Accepted: September 05, 2017 Published: October 04, 2017

ABSTRACT

Melanoma, a cancer derived from melanocytes, is one of the most chemoresistant cancers and tends to metastasize. Once it metastasizes, the prognosis is poor. Even with the recent advancement of targeted therapy and immunotherapy, the prognosis remains discouraging. SR-T100, a Solanum incanum extract, shows anticancer effects against several cancers; however, its therapeutic efficacy against melanoma and established metastasis remains unknown. In this study, we showed that SR-T100 induces apoptosis, DNA damage, and G0/G1 cell cycle arrest in murine B16 melanoma cells in vitro. In vivo, intralesional injection of SR-T100 decreased the tumor size of the regional melanoma in the foot pad. Moreover, intraperitoneal injection of SR-T100 inhibited the growth and the number of established melanoma metastases in the lungs. Our study highlights SR-T100 as a potential novel treatment for established tumors from regional and metastatic melanoma.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21508

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Solanum incanum extract (SR-T100) induces melanoma cell apoptosis and inhibits established lung metastasis

Abstract